What is Mesa Laboratories Inc worth?
With the base-case assumptions below, a discounted cash flow model on Mesa Laboratories Inc's reported free cash flow gives $201.74 per share. The share price was $136.91 on November 10, 2026, 32% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 8.0% | 10.0% | $119.90 | -12% |
| Base | 13.0% | 9.0% | $201.74 | +47% |
| Bull | 18.0% | 8.0% | $354.25 | +159% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $263.07 | $282.11 | $305.39 | $334.48 | $371.88 |
| 8.0% | $217.06 | $229.41 | $244.01 | $261.52 | $282.92 |
| 9.0% | $183.56 | $192.00 | $201.74 | $213.11 | $226.54 |
| 10.0% | $158.13 | $164.13 | $170.94 | $178.71 | $187.69 |
| 11.0% | $138.21 | $142.61 | $147.53 | $153.07 | $159.34 |
Where the presets come from
Base: years 1 to 5 grow at Mesa Laboratories Inc's revenue growth rate over the last 5 fiscal years (13.2% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions